Professional Documents
Culture Documents
Primary Hyperparathyroidism
parathyroid adenoma/hyperplasia
Parathyroid Hormone MEN 1
secreted from four parathyroid glands in the region of result in tumors of the parathyroids,
the thyroid gland pituitary, and pancreas
loss of a tumor suppressor gene that
maps to human chromosome 11
MEN 2
result in tumors of the parathyroids, refers to the abnormal mineralization
medullary thyroid hyperplasia or of bone in adults, or after closure of
cancer, and pheochromocytoma the ephiphysial plates.
activating mutation in the ret proto- Osteoporosis
oncogene, which resides on human the most prevalent metabolic bone
chromosome 10 disease in adults.
Familial hyperparathyroidism
results in primary HPT, without other associated tumors
mapped to human chromosome 1.14
Familial hypocalciuric hypercalcemia (FHH)
result of a mutation in the calcium- sensing receptor and
thus an increased “set point” for calcium homeostasis
mild hypercalcemia and hyperparathyroidism
CAUSES OF HYPOTHYROIDISM
Thyrotoxicosis
constellation of findings that result when
peripheral tissues are presented with, and
respond to, an excess of thyroid hormone.
Clinical Chemistry 3 Lecture 6 Almost all proteins are
LIVER FUNCTION synthesized by the liver
Gross Anatomy Of The Liver except for the
Blood Supply of the Liver immunoglobulins and adult
Excretory System Of The Liver hemoglobin
Microscopic Anatomy DETOXIFICATION AND DRUG METABOLISM
BIOCHEMICAL FUNCTIONS serves as a gatekeeper between substances
Four Major Functions: absorbed by the gastrointestinal tract and those
Excretion/secretion released into systemic circulation
Synthesis LIVER FUNCTION ALTERATIONS DURING DISEASE
Detoxification JAUNDICE
Storage Upper normal limit of total bilirubin
EXCRETORY AND SECRETORY 1.0-1.5 mg/dL
Transforms unconjugated to conjugated Jaundice is noticeable at 3.0 mg/dL
bilirubin ICTERUS
Ligandin used in the clinical laboratory to refer to a serum
responsible for transporting or plasma sample with a yellow discoloration
unconjugated bilirubin to the due to an elevated bilirubin level
endoplasmic reticulum, CLASSIFICATION OF JAUNDICE
where it may be rapidly
conjugated
METABOLISM OF BILIRUBIN
GILBERT DISEASE
reduced activity of the enzyme
glucuronyltransferase, which conjugates bilirubin
and a few other lipophilic molecules
CRIGLER-NAJJAR SYNDROME TYPE 1
Mode of Inheritance:
Autosomal Recessive
characterised by:
serum bilirubin usually above 345
µmol/L (310–755 mg/dL)
no UGT1A1 (UDP
glucuronosyltransferase 1 family,
SYNTHETIC polypeptide A1) expression
Responsible for synthesizing: no response to treatment with
Carbohydrates phenobarbital*
use the glucose for its own CRIGLER-NAJJAR SYNDROME TYPE 2
cellular energy requirements Type II differs from type I in several aspects:
circulate the glucose for use Bilirubin levels are generally below 345
at the peripheral tissues µmol/L (100–430 mg/dL) and some
store glucose as glycogen cases are only detected later in life.
(principal storage form of Because of lower serum bilirubin,
glucose) within the liver itself kernicterus is rare in type II.
or within other tissues Bile is pigmented, instead of pale in
Lipids type I or dark as normal, and
approximately 70% of the monoconjugates constitute the largest
daily production of fraction of bile conjugates.
cholesterol (roughly 1.5–2.0 UGT1A1 is present at reduced but
g) detectable levels (typically <10% of
Proteins
normal), because of single base pair inherited disorders (e.g., α1-antitrypsin
mutations. deficiency, Wilson disease,
Therefore, treatment with hemachromatosis, and galactosemia)
phenobarbital is effective, generally nonalcoholic steatohepatitis
with a decrease of at least 25% in blocked bile ducts
serum bilirubin. In fact, this can be Drugs
used, along with these other factors, to Toxins
differentiate type I and II. infections
The inheritance pattern of Crigler– REYE SYNDROME
Najjar syndrome type II has been a term used to describe a group of disorders
difficult to determine but is generally caused by infectious, metabolic, toxic, or drug-
[
considered to be autosomal recessive. induced disease found almost exclusively in
DUBIN-JOHNSON SYNDROME children
An autosomal recessive disorder Associted with:
Increase of conjugated bilirubin in the serum viral syndrome
without elevation of liver enzymes (ALT, AST) Varicella
Defect in the ability of hepatocytes to secrete Gastroenteritis
conjugated bilirubin into the bile upper respiratory tract
Diagnosis infection such as influenza
A hallmark of DJS is the unusual ratio aspirin during a viral syndrome
between the byproducts of heme ASSESSMENT OF LIVER FUNCTION/LIVER FUNCTION
biosynthesis. TESTS
Unaffected subjects have a Review:
coproporphyrin III to BILIRUBIN
coproporphyrin I ratio of Ehrlich’s (Diazo) Reaction
approximately 3–4:1. diazotized Sulfanilic Acid +
In patients with DJS, this Urine colored product
ratio is inverted with (RED)= urobilinogen
coproporphyrin I being 3–4x Van den Bergh Reaction
higher than coproporphyrin determines the amount of
III. conjugated bilirubin in the
ROTOR SYNDROME blood
the reaction produces
azobilirubin
Principle: diazotised sulfanilic
acid + serum + stabilizer =
produce purple colored
azobilirubin
Malloy and Evelyn Reaction
Principle: diazotised sulfanilic
acid + serum + 50% methanol
(accelerator)= RED PURPLE
Jendrassik and Grof
Principle: diazotised sulfanilic
acid + serum + caffeine-
benzoate-acetate
(accelerator)= PURPLE
CIRRHOSIS REFERENCE RANGES FOR BILIRUBIN IN
clinical condition in which scar tissue replaces ADULTS AND INFANTS
normal, healthy liver tissue
scar tissue replaces the normal liver tissue
blocking the flow of blood through the organ and
prevents the liver from functioning properly
Causes:
Chronic Alcoholism
Chronic Hepatitis B, C, D
autoimmune hepatitis
DETERMINATION OF UROBILINOGEN membrane-localized enzyme found in
(SEMIQUANTITATIVE) high concentrations in the kidney, liver,
Principle pancreas, intestine, and prostate but
Urobilinogen (Urine) + p-dimethyl not in bone
aminobenzaldehyde (Ehrlich’s reagent) plays a role in differentiating the cause
= red color of elevated levels of ALP
Reference Range (Urine) highest levels of GGT are
0.1–1.0 Ehrlich units every 2 hours seen in biliary obstruction
0.5–4.0 Ehrlich units per day (0.86.8 hepatic microsomal enzyme
mmol/day) ingestion of alcohol or
Reference Range (Fecal) certain drugs elevates GGT
75–275 Ehrlich units per 100 g of fresh Barbiturates
feces Tricyclic
75–400 Ehrlich units per 24-hour Antidepressants
specimen Anticonvulsants
LIVER ENZYMES a sensitive test for cholestasis caused
Most Clinically Useful: by chronic alcohol or drug ingestion
Aminotranferases useful if jaundice is absent for the
alanine amino transferase [ALT] confirmation of hepatic neoplasms
SGPT an enzyme with a very wide
aspartate aminotransferase [AST]) distribution throughout the body
SGOT released into circulation when cells of
Phosphatases the body are damaged or destroyed
alkaline phosphatase [ALP] serves as a general, nonspecific marker
5’- neucleotidase) of cellular injury
Gamma -glutamyltransferase (GGT) Tests Measuring Hepatic Synthetic Ability
Lactate dehydrogenase SERUM PROTEINS
AMINOTRANFERASES Useful in quantitating the severity of hepatic
ALT a more “liver-specific” marker than AST dysfunction
the serum activity of both transaminases rises Not sensitive to minimal liver damage
rapidly in almost all diseases of the liver and may SERUM ALBUMIN
remain elevated for up to 2–6 weeks correlates well with the severity of functional
Markedly increased in: impairment
viral hepatitis chronic rather than in acute liver disease
drug- and toxin-induced liver necrosis (decreased)
Hepatic ischemia SERUM α-GLOBULINS
Normal or only mildly elevated in: decrease with chronic liver disease
cases of obstructive liver damage low or absent α-globulin suggests α-
PHOSPHATASES antitrypsin deficiency as the cause of
Alkaline Phosphatase the chronic liver disease
zinc metalloenzymes SERUM γ-GLOBULIN
widely distributed in all tissues transiently increased in acute liver
marker of extrahepatic biliary obstruction disease
stone in the common bile duct elevated in chronic liver disease
intrahepatic cholestasis IgG and IgM levels chronic
drug cholestasis active hepatitis
primary biliary cirrhosis IgM Primary Biliary
moderate increase: Cirrhosis
hepatocellular disorders such as hepatitis and IgA Alcoholic Cirrhosis
cirrhosis PROTHROMBIN
5’-Nucleotidase Decreased
responsible for catalyzing the Prothrombin Time is prolonged
hydrolysis of neucleoside-5’-phosphate Indicates severe diffuse liver disease
ester and a poor prognosis
serum levels become significantly Tests Measuring Nitrogen Metabolism
elevated in hepatobiliary disease PLASMA AMMONIA
more liver specific compared to ALP
PHOSPHATASES
a reflection of the liver’s ability to SEROLOGICAL PROFILES OF CHRONIC HEPATITIS B VIRUS
convert ammonia to urea so that it can INFECTION
be excreted through the kidneys
increase in the bloodstream and may
ultimately cause hepatic coma
HEPATITIS